Challenging pedigrees seen in a hereditary cancer consultation center

Cancer Genetics and Cytogenetics

Volumn 153, Issue 2, 2004, Pages 91-101

  Lynch, Henry T ^a   Tinley, Susan T ^a   Lynch, Jane F ^a   Attard, Thomas M ^b  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER CENTER; CANCER DIAGNOSIS; CANCER GENETICS; CANCER RISK; CANCER SCREENING; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONFIDENTIALITY; CONSULTATION; CONTROLLED STUDY; ECONOMIC ASPECT; EMPLOYMENT; FAMILIAL CANCER; FEMALE; HEALTH INSURANCE; HUMAN; MALE; MOLECULAR GENETICS; PATHOLOGY; PATIENT CARE; PATIENT COMPLIANCE; PEDIGREE; PRIORITY JOURNAL; SOCIAL PSYCHOLOGY;

AGED; FEMALE; HUMANS; MALE; MUTATION; NEOPLASMS; PEDIGREE; REPRODUCIBILITY OF RESULTS;

EID: 9944256937     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2004.01.011     Document Type: Article

References (28)

1. B. Voglestein K.W. Kinzler The genetic basis of human cancer 1998 McGraw-Hill New York
2. H.T. Lynch Family information service and hereditary cancer Cancer 91 2001 625 628
3. S.J. Lemon, S.T. Tinley, R.M. Fusaro, and H.T. Lynch Cancer risk assessment in a hereditary cancer prevention clinic and its first year's experience Cancer 80 Suppl 1997 606 613
4. H.T. Lynch, and A. de la Chapelle Genetic susceptibility to non-polyposis colorectal cancer J Med Genet 36 1999 801 818
5. H.T. Lynch, and A. de la Chapelle Hereditary colorectal cancer N Engl J Med 348 2003 919 932
6. H.T. Lynch, C.L. Snyder, J.F. Lynch, B.D. Riley, and W.S. Rubinstein Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist J Clin Oncol 21 2003 740 753
7. H.T. Lynch, C.A. Deters, D. Hogg, J.F. Lynch, Y. Kinarsky, and Z. Gatalica Familial sarcoma: challenging pedigrees Cancer 98 2003 1947 1957
8. M.G. Sayed, A.F. Ahmed, J.R. Ringold, M.E. Anderson, J.L. Bair, F.A. Mitros, H.T. Lynch, S.T. Tinley, G.M. Petersen, F.M. Giardiello, B. Vogelstein, and J.R. Howe Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis Ann Surg Oncol 9 2002 901 906
9. F.E.M. Rijcken, T. van der Sluis, H. Hollema, and J.H. Kleibeuker Hyperplastic polyps in hereditary nonpolyposis colorectal cancer Am J Gastroenterol 98 2003 2306 2311
10. A. Balmain, J. Gray, and B. Ponder The genetics and genomics of cancer Nat Genet 33 Suppl 2003 238 244
11. C.M. Ribic, D.J. Sargent, M.J. Moore, S.N. Thibodeau, A.J. French, R.M. Goldberg, S.R. Hamilton, P. Laurent-Puig, R. Gryfe, L.E. Shepherd, D. Tu, M. Redston, and S. Gallinger Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N Engl J Med 349 2003 247 257
12. H.T. Lynch, R.D. McComb, N.K. Osborn, P.A. Wolpert, J.F. Lynch, Z.K. Wszolek, D. Sidransky, and R.E. Steg Predominance of brain tumors in an extended Li-Fraumeni (SBLA) kindred, including a case of Sturge-Weber syndrome Cancer 88 2000 433 439
13. S.K. Gupta, J.F. Fitzgerald, J.M. Croffie, S.K. Chong, M.C. Pfefferkorn, M.M. Davis, and P.R. Faught Experience with juvenile polyps in North American children: the need for pancolonoscopy Am J Gastroenterol 96 2001 1695 1697
14. T.M. Attard, T. Tajouri, C. Reyes, J.H. Yardley, H.T. Lynch, and C. Cuffari Multicenter experience in gastroduodenal polyps in pediatric patients with adenomatous polyposis: are current screening guidelines adequate? [Abstract] J Pediatr Gastroenterol Nutr 35 2002 426
15. F.M. Giardiello, S.R. Hamilton, S.E. Kern, G.J.A. Offerhaus, P.A. Green, P. Celano, A.J. Krush, and S.V. Booker Colorectal neoplasia in juvenile polyposis or juvenile polyps Arch Dis Child 66 1991 971 975
16. P.C.I. Schroy, A.F. Barrison, B.S. Ling, S. Wilson, and A.C. Geller Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns Am J Gastroenterol 97 2002 1031 1036
17. A.F. Barrison, C. Smith, J. Oviedo, T. Heeren, and P.C.I. Schroy Colorectal cancer screening and familial risk: a survey of internal medicine residents' knowledge and practice patterns Am J Gastroenterol 98 2003 1410 1416
18. M.K. Cho, P. Sankar, P.R. Wolpe, and L. Godmilow Commercialization of BRCA1/2 testing: practitioner awareness and use of a new genetic test Am J Med Genet 83 1999 157 163
19. F.M. Giardiello, J.D. Brensinger, G.M. Petersen, M.C. Luce, L.M. Hylind, J.A. Bacon, S.V. Booker, R.D. Parker, and S.R. Hamilton The use and interpretation of commercial APC gene testing for familial adenomatous polyposis N Engl J Med 336 1997 823 827
20. K. Aktan-Collan, J.-P. Mecklin, H. Jarivnen, M. Nystrom-Lahti, P. Peltomaki, I. Soderling, A. Uutela, A. de la Chapelle, and H. Kaariainen Predictive genetic testing for hereditary non-polyposis colorectal cancer: Uptake and long-term satisfaction Int J Cancer 89 2000 44 50
21. E.T. Matloff, H. Shappell, K. Brierley, B.A. Bernhardt, W. McKinnon, and B.N. Peshkin What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination J Clin Oncol 18 2000 2484 2492
22. R.J. Pokorski, P. Sanderson, N. Bennett, M. Costanza, A.A. Dicke, H. Eyre, P.H. Hall, S. Hausman, J. Lynch, R.B. Meyer, S. Sener, R. Wender, and K. Zeitz Insurance issues and genetic testing: challenges and recommendations: workshop no. 1 Cancer 80 Suppl 1997 627
23. D.W. Hadley Background statement: genetic testing and insurance Am J Hum Genet 56 1995 327 331
24. Ad Hoc Committee on Genetic Testing/Insurance Issues of the American Society of Human Genetics, J. Jenkins, E. Dimond, K. Nakahara, L. Grogan, D.J. Liewehr, S.M. Steinberg, and I. Kirsch Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer Arch Intern Med 163 2003 573 582
25. 105th Congress. Balanced Budget Act of 1997. Public Law 105-33. August 5, 1997. Stat. 111. 251.
26. B.J. Druker, M. Talpaz, D.J. Resta, B. Peng, E. Buchdunger, J.M. Ford, N.B. Lydon, H. Kantarjian, R. Capdeville, S. Ohno-Jones, and C.L. Sawyers Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia N Engl J Med 344 2001 1031 1037
27. B.J. Druker, C.L. Sawyers, H. Kantarjian, D.J. Resta, S.F. Reese, J.M. Ford, R. Capdeville, and M. Talpaz Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome N Engl J Med 344 2001 1038 1042 [Erratum: N Engl J Med 2001;345:232.]
28. A. de la Chapelle Microsatellite instability N Engl J Med 349 2003 209 210